ENTRY       D03117                      Drug
NAME        Binetrakin (USAN/INN)
SEQUENCE    HKCDITLQEI IKTLNSLTEQ KTLCTELTVT DIFAASKNTT EKETFCRAAT VLRQFYSHHE
            KDTRCLGATA QQFHRHKQLI RFLKRLDRNL WGLAGLNSCP VKEANQSTLE NFLERLKTIM
            REKYSKCSS
            (Disulfide bridge: 3-127, 24-65, 46-99)
  TYPE      Peptide
EFFICACY    Antineoplastic, Antirheumatic, Immunomodulator
COMMENT     interleukin 4 (IL4) analog [HSA:3565] [KO:K05430]
            Treatment of gastrointestinal carcinoma, rheumatoid arthritis and dendritic cell activation (immunomodulatory activities on B cells, macrophages, eosinophils and other hematopoietic cells)
TARGET      IL4 [HSA:3565] [KO:K05430]
  PATHWAY   hsa04060(3565)  Cytokine-cytokine receptor interaction
            hsa04151(3565)  PI3K-Akt signaling pathway
            hsa04630(3565)  JAK-STAT signaling pathway
            hsa04664(3565)  Fc epsilon RI signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Interleukins
                IL4
                 D03117  Binetrakin (USAN/INN)
DBLINKS     CAS: 207137-56-2
            PubChem: 17397272
///
